Ranitidine Hydrochloride Tablets
Function and Efficacy
This product is an H2 receptor inhibitor, which has the effect of inhibiting gastric acid secretion. It is rapidly absorbed through the gastrointestinal tract after oral administration.
Ingredients
The main ingredient of this product is: Ranitidine hydrochloride. Its chemical name is: N'-methyl-N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]-methyl]thio]ethyl]-2-nitro-1,1-ethylenediamine hydrochloride. Molecular formula: C13H22N4O3SHCl Molecular weight: 350.87
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Ranitidine HydrochlorideIngredients |
H2 receptor inhibitor, which has the effect of inhibiting gastric acid secretion. It is rapidly absorbed through the gastrointestinal tract after oral administration. More |
66357-59-3 | 48 |
Appearance
This product is a sugar-coated tablet or a film-coated tablet, which appears off-white or slightly yellow after removing the coating.
Indication
Used to relieve stomach pain, heartburn and acid reflux caused by excessive stomach acid.
Usage and Dosage
Oral administration, 2 tablets at a time, twice a day, morning and evening. Do not exceed 4 tablets in 24 hours.
Adverse Reactions
1 Common symptoms include: nausea, rash, constipation, fatigue, headache, dizziness, etc.; 2 Adverse reactions to renal function, gonadal function and central nervous system are relatively mild; 3 A small number of patients suffer from mild liver damage after taking the medicine, and the symptoms disappear after stopping the medicine, and liver function returns to normal.
Precautions
It is contraindicated for those who are allergic to this product.
Special Population Medication
Precautions for children: Children under 8 years old are prohibited. Precautions for pregnancy and lactation: Precautions for pregnant and lactating women. Precautions for the elderly: The liver and kidney functions of the elderly are reduced. To ensure the safety of medication, the dosage should be adjusted.
Drug Interactions
1. When used in combination with procainamide, the clearance rate of procainamide can be reduced; 2. It can reduce hepatic blood flow, and therefore when used in combination with drugs such as propranolol and lidocaine whose metabolism is greatly affected by hepatic blood flow, the effects of these drugs can be delayed.
Storage
Keep away from light, sealed and stored in a dry place.
Packaging Specification
0.15g (calculated as C13H22N4O3S)
Validity Period
24 months
Manufacturer
Zengcheng Guangzhou Ouhua Pharmaceutical Co., Ltd.
-
Founded in:
1993-12-29 -
Address:
Room 1701, Building 3, No. 14, Innovation Avenue, Ningxi Street, Zengcheng District, Guangzhou -
Tax NO.:
91440183618793970T -
Registered Funds:
HK$17.5 million -
Website:
-
Email: